Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
‌
Share
Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
By clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌
1/28/2025
Energy
Atlas Energy’s Strategic Power Play: $220M Moser Energy Acquisition
Atlas Energy Solutions (NYSE: AESI) is making a bold move into the distributed power market with its $220 million acquisition of Moser Energy Systems, marking a significant expansion beyond its...
‌
1/28/2025
Health
Release – Unicycive Therapeutics Announces the Publication of Patient Perspectives on Phosphate Management in the Journal of Nephrological Science
Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced the publication of a review on patient perspectives regarding...
‌
1/28/2025
Consumer
The ODP Corporation (ODP) – Expanding the Addressable Market
A Hospitality Agreement. The ODP Corporation’s Business Solutions segment entered into a key new partnership with one of the world’s largest hotel management organizations, becoming a preferred provider for operating supplies and...
Raising Price Target. We are maintaining our Outperform rating but raising our price target on KTOS shares to $38 from a prior $30. KTOS shares have performed well since we raised...
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.
